You are in: eMedicine Specialties > Pulmonology > Aspiration and Atelectasis AtelectasisArticle Last Updated: Jun 14, 2006AUTHOR AND EDITOR INFORMATIONAuthor: Sat Sharma, MD, FRCPC, Professor and Head, Division of Pulmonary Medicine, Department of Internal Medicine, University of Manitoba; Site Director, Respiratory Medicine, St. Boniface General Hospital Sat Sharma is a member of the following medical societies: American Academy of Sleep Medicine, American College of Chest Physicians, American College of Physicians-American Society of Internal Medicine, American Thoracic Society, Canadian Medical Association, Royal College of Physicians and Surgeons of Canada, Royal Society of Medicine, Society of Critical Care Medicine, and World Medical Association Editors: Helen M Hollingsworth, MD, Director, Adult Asthma and Allergy Services, Associate Professor, Department of Internal Medicine, Division of Pulmonary and Critical Care, Boston Medical Center; Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine; Robert S Crausman, MD, MMS, Chief Administrative Officer, Rhode Island Board of Medical Licensure and Discipline, Rhode Island Department of Health; Associate Professor, Department of Medicine, Brown University School of Medicine; Timothy D Rice, MD, Associate Professor, Departments of Internal Medicine and Pediatrics and Adolescent Medicine, Saint Louis University School of Medicine; Zab Mosenifar, MD, Director, Division of Pulmonary and Critical Care Medicine, Director, Women's Guild Pulmonary Disease Institute, Executive Vice Chair, Department of Medicine, Cedars Sinai Medical Center; Professor of Medicine, David Geffen School of Medicine at UCLA Author and Editor Disclosure Synonyms and related keywords: atelectasis, incomplete expansion, diminished lung volume, pulmonary volume deficiency, lung deficiency, lung foreign body, lung tumor, mucus plugging, pleural effusion, pneumothorax, acute respiratory distress syndrome, ARDS, granulomatous disease, necrotizingpneumonia, bronchioalveolar cell carcinoma, right middle lobe syndrome, atelectatic lung tissue, bronchial obstruction, pulmonary atelectasis, obstructive atelectasis, lobar atelectasis, segmental atelectasis, nonobstructive atelectasis, relaxation atelectasis, passive atelectasis, compression atelectasis, space-occupying lesion of thorax, adhesive atelectasis, surfactant deficiency, decreased production of surfactant, inactivation of surfactant, cicatrization atelectasis, replacement atelectasis, chronic atelectasis, acute pneumonitis, chronicpneumonitis, rounded atelectasis, radiation pneumonitis, discoid atelectasis, subsegmental atelectasis, platelike atelectasis, pulmonary embolism, lower respiratory tract infection, postoperative atelectasis, plugs of tenacious sputum, endobronchial tumors, adenocarcinoma of breast, bronchogenic carcinoma, adenocarcinoma of thyroid, hypernephroma, melanoma, chronic tuberculosis, fungal infection, aspirated foreign body, malpositioned endotracheal tube, INTRODUCTIONBackgroundThe term atelectasis is derived from the Greek words ateles and ektasis, which mean incomplete expansion. Atelectasis is defined as diminished volume affecting all or part of a lung. Pulmonary atelectasis is one of the most commonly encountered abnormalities in chest radiology findings. Recognizing an abnormality due to atelectasis on chest x-ray films can be crucial to understanding the underlying pathology. Several types of atelectasis exist; each has a characteristic radiographic pattern and etiology. Atelectasis is divided physiologically into obstructive and nonobstructive causes. Obstructive atelectasis Obstructive atelectasis is the most common type and results from reabsorption of gas from the alveoli when communication between the alveoli and the trachea is obstructed. The obstruction can occur at the level of the larger or smaller bronchus. Causes of obstructive atelectasis include foreign body, tumor, and mucous plugging. The rate at which atelectasis develops and the extent of atelectasis depend on several factors, including the extent of collateral ventilation that is present and the composition of inspired gas. Obstruction of a lobar bronchus is likely to produce lobar atelectasis; obstruction of a segmental bronchus is likely to produce segmental atelectasis. Because of the collateral ventilation without a lobe or between segments, the pattern of atelectasis often depends on collateral ventilation, which is provided by the pores of Kohn and the canals of Lambert. Nonobstructive atelectasis Nonobstructive atelectasis can be caused by loss of contact between the parietal and visceral pleurae, compression, loss of surfactant, and replacement of parenchymal tissue by scarring or infiltrative disease. Examples of nonobstructive atelectasis are described in the following paragraphs. Relaxation or passive atelectasis results when a pleural effusion or a pneumothorax eliminates contact between the parietal and visceral pleurae. Generally, the uniform elasticity of a normal lung leads to preservation of shape even when volume is decreased. The different lobes also function differently, eg, the middle and lower lobes collapse more than the upper lobe in the presence of pleural effusion, while the upper lobe may be affected more by pneumothorax. Compression atelectasis occurs from any space-occupying lesion of the thorax compressing the lung and forcing air out of the alveoli. The mechanism is similar to relaxation atelectasis. Adhesive atelectasis results from surfactant deficiency. Surfactant normally reduces the surface tension of the alveoli, thereby decreasing the tendency of these structures to collapse. Decreased production or inactivation of surfactant leads to alveolar instability and collapse. This is observed particularly in acute respiratory distress syndrome (ARDS) and similar disorders. Cicatrization atelectasis results from diminution of volume as a sequela of severe parenchymal scarring and is usually caused by granulomatous disease or necrotizing pneumonia. Replacement atelectasis occurs when the alveoli of an entire lobe are filled by tumor (eg, bronchioalveolar cell carcinoma), resulting in loss of volume. Right middle lobe syndrome is a form of chronic atelectasis that usually results from bronchial compression by surrounding lymph nodes. Partial bronchial obstruction and recurrent infection also may lead to chronic atelectasis and acute or chronic pneumonitis. Rounded atelectasis represents folded atelectatic lung tissue with fibrous bands and adhesions to the visceral pleura. Incidence is high in asbestos workers (65-70% of cases), most likely due to a high degree of pleural disease. Affected patients typically are asymptomatic, and the mean age at presentation is 60 years. PathophysiologyThe mechanism of obstructive and nonobstructive atelectasis is quite different and is determined by several factors. Obstructive atelectasis Following obstruction of a bronchus, the circulating blood absorbs the gas in the peripheral alveoli, leading to retraction of the lung and an airless state within a few hours. In the early stages, blood perfuses the airless lung; this results in ventilation-perfusion mismatch and arterial hypoxemia. A filling of the alveolar spaces with secretions and cells may occur, thereby preventing complete collapse of the atelectatic lung. The uninvolved surrounding lung tissue distends, displacing the surrounding structures. The heart and mediastinum shift toward the atelectatic area, the diaphragm is elevated, and the chest wall flattens. If the obstruction is removed, any complicating postobstructive infection subsides and the lung returns to its normal state. If the obstruction is persistent and infection continues to be present, fibrosis develops and the lung becomes bronchiectatic. Nonobstructive atelectasis The loss of contact between the visceral and parietal pleurae is the primary cause of nonobstructive atelectasis. A pleural effusion or pneumothorax causes relaxation or passive atelectasis. Pleural effusions affect the lower lobes more commonly than pneumothorax, which affects the upper lobes. A large pleural-based lung mass may cause compression atelectasis by decreasing lung volumes. Adhesive atelectasis is caused by a lack of surfactant. The surfactant has phospholipid dipalmitoyl phosphatidylcholine, which prevents lung collapse by reducing the surface tension of the alveoli. Lack of production or inactivation of surfactant, which may occur in ARDS, radiation pneumonitis, and blunt trauma to the lung, cause alveolar instability and collapse. Middle lobe syndrome (recurrent atelectasis and/or bronchiectasis involving the right middle lobe and/or lingula) has recently been reported as the pulmonary manifestation of primary Sjögren syndrome. Scarring of the lung parenchyma leads to cicatrization atelectasis. Replacement atelectasis is caused by filling of the entire lobe by a tumor such as bronchoalveolar carcinoma. Platelike atelectasis Also called discoid or subsegmental atelectasis, this type is seen most commonly on chest radiographs. Platelike atelectasis probably occurs because of obstruction of a small bronchus and is observed in states of hypoventilation, pulmonary embolism, or lower respiratory tract infection. Small areas of atelectasis occur because of inadequate regional ventilation and abnormalities in surfactant formation from hypoxia, ischemia, hyperoxia, and exposure to various toxins. A mild-to-severe gas exchange abnormality may occur because of ventilation-perfusion mismatch and intrapulmonary shunt. Postoperative atelectasis Atelectasis is a common pulmonary complication in patients following thoracic and upper abdominal procedures. General anesthesia and surgical manipulation lead to atelectasis by causing diaphragmatic dysfunction and diminished surfactant activity. The atelectasis is typically basilar and segmental in distribution. FrequencyUnited StatesPostoperative atelectasis is extremely common. Lobar atelectasis is also common. The incidence and prevalence of this disorder are not well documented. Mortality/MorbidityPatient mortality depends on the underlying cause of atelectasis. In postoperative atelectasis, the condition generally improves. The prognosis of lobar atelectasis secondary to endobronchial obstruction depends on treatment of the underlying malignancy. RaceNo racial predilection exists. SexNo sexual predilection exists. AgeThe mean age at presentation for rounded atelectasis is 60 years. CLINICALHistoryAtelectasis may occur postoperatively following thoracic or upper abdominal procedures.
PhysicalThe physical examination findings show dullness to percussion over the involved area and diminished or absent breath sounds. Chest excursion in the area is reduced or absent. The trachea and the heart are deviated toward the affected side. Causes
DIFFERENTIALSAsbestosis Ascites Blunt Chest Trauma Diaphragmatic Paralysis Hypersensitivity Pneumonitis Lung Abscess Lung Cancer, Non-Small Cell Lung Cancer, Oat Cell (Small Cell) Pneumococcal Infections Pneumonia, Aspiration Pneumonia, Bacterial Pneumonia, Community-Acquired Pneumonia, Fungal Pneumonia, Viral Pneumothorax Pulmonary Embolism Pulmonary Fibrosis, Idiopathic Respiratory Failure
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Drug Name | Albuterol (Proventil, Ventolin) |
|---|---|
| Description | Beta-agonist for bronchospasm refractory to epinephrine. Relaxes bronchial smooth muscle by action on beta-2 receptors, with little effect on cardiac muscle contractility. Most patients (even those with no measurable increase in expiratory flow) benefit from treatment. Inhaled beta-agonists initially are prescribed prn. Frequency may be increased; institute regular schedule in patients on anticholinergic drugs who are still symptomatic. Available as a liquid for nebulizer, metered-dose inhalers (MDI), and dry-powder inhalers. |
| Adult Dose | MDI: 2 puffs q3-4h Nebulizer: 0.2-0.3 mL of 5% solution diluted to 2.5 mL with NS tid/qid |
| Pediatric Dose | MDI <12 years: Not recommended >12 years: Administer as in adults Nebulizer Infants and children: 0.01-0.02 mL of 5% solution diluted in 2-3 mL NS q4-6h Adolescents: Administer as in adults |
| Contraindications | Documented hypersensitivity; preexisting cardiac arrhythmia associated with tachycardia |
| Interactions | Beta-adrenergic blockers antagonize effects; inhaled ipratropium may increase duration of bronchodilatation; cardiovascular effects may increase with MAOIs, inhaled anesthetics, TCAs, and sympathomimetic agents |
| Pregnancy | C - Safety for use during pregnancy has not been established. |
| Precautions | Adverse effects include muscle tremor, nervousness, insomnia, transient hypoxemia, and tachycardia; caution in hyperthyroidism, diabetes mellitus, hypertension, ischemic heart disease, seizures, and pheochromocytoma |
| Drug Name | Metaproterenol (Alupent) |
|---|---|
| Description | Relaxes bronchial smooth muscle by action on beta-2 receptors, with little effect on cardiac muscle contractility. Most patients (even those with no measurable increase in expiratory flow) benefit from treatment. Inhaled beta-agonists initially are prescribed prn. Frequency may be increased; institute regular schedule in patients on anticholinergic drugs who are still symptomatic. Available as a liquid for nebulizer, MDI, and dry-powder inhaler. |
| Adult Dose | MDI: 2 puffs q3-4h Nebulizer: 0.2-0.3 mL of 5% solution diluted to 2.5 mL with NS tid/qid |
| Pediatric Dose | MDI <12 years: Not recommended >12 years: Administer as in adults Nebulizer Infants and children: 0.01-0.02 mL of 5% solution diluted in 2-3 mL of NS q4-6h Adolescents: Administer as in adults |
| Contraindications | Documented hypersensitivity; arrhythmia associated with tachycardia |
| Interactions | Beta-adrenergic blockers antagonize effects; inhaled ipratropium may increase duration of bronchodilatation; cardiovascular effects may increase with MAOIs, inhaled anesthetics, TCAs, and sympathomimetic agents |
| Pregnancy | C - Safety for use during pregnancy has not been established. |
| Precautions | Caution in hypertension, cardiovascular disease, congestive heart failure, hyperthyroidism, diabetes, and seizures; not recommended during breastfeeding; adverse reactions include tachycardia, headache, nervousness, dizziness, tremor, GI upset, hypertension, paradoxical bronchospasm, and cough |
N-acetylcysteine is only recommended for direct instillation via fiberoptic bronchoscopy or in an intubated patient. Therapy with mucolytics may promote sputum removal of thick mucous plugs and, therefore, helps treat atelectasis in many patients.
| Drug Name | N-acetylcysteine (Mucomyst) |
|---|---|
| Description | Inhalations may be tried to encourage sputum expectoration in patients with tenacious sputum and mucous plugging. |
| Adult Dose | 5-10 mg dissolved in 3 mL NS |
| Pediatric Dose | Not established |
| Contraindications | Documented hypersensitivity |
| Interactions | None reported |
| Pregnancy | B - Usually safe but benefits must outweigh the risks. |
| Precautions | Inhalations may exacerbate bronchospasm; GI distress may occur |
To treat underlying bronchitis or postobstructive infection.
| Drug Name | Cefuroxime (Zinacef) |
|---|---|
| Description | Second-generation cephalosporin maintains gram-positive activity of first-generation cephalosporins; adds activity against Proteus mirabilis, Haemophilus influenzae, Escherichia coli, Klebsiella pneumoniae, and Moraxella catarrhalis. Condition of patient, severity of infection, and susceptibility of microorganism determine proper dose and route of administration. |
| Adult Dose | 2 g IV q6-8h |
| Pediatric Dose | 80-160 mg/kg/d IV divided q4-6h |
| Contraindications | Documented hypersensitivity |
| Interactions | Alcoholic beverages consumed <72 h after taking may produce disulfiramlike reactions; may increase hypoprothrombinemic effects of anticoagulants; may increase nephrotoxicity in patients receiving potent diuretics (eg, loop diuretics); coadministration with aminoglycosides increases nephrotoxic potential |
| Pregnancy | B - Usually safe but benefits must outweigh the risks. |
| Precautions | Administer half dose if CrCl is 10-30 mL/min and quarter dose if CrCl <10 mL/min; fungal and microorganism overgrowth may occur with prolonged therapy |
| Drug Name | Cefaclor (Ceclor) |
|---|---|
| Description | Second-generation cephalosporin indicated for infections caused by susceptible gram-positive cocci and gram-negative rods. Determine proper dosage and route based on condition of patient, severity of infection, and susceptibility of causative organisms. |
| Adult Dose | 500 mg PO tid for 10 d |
| Pediatric Dose | 20-40 mg/kg/d PO q8-12h |
| Contraindications | Documented hypersensitivity |
| Interactions | Alcoholic beverages consumed <72 h after taking may produce disulfiramlike reactions; may increase hypoprothrombinemic effects of anticoagulants; coadministration with potent diuretics (eg, loop diuretics) and aminoglycosides may increase nephrotoxicity; monitor renal function closely |
| Pregnancy | B - Usually safe but benefits must outweigh the risks. |
| Precautions | Reduce dosage by half if CrCl is 10-30 mL/min and by one fourth if CrCl <10 mL/min; bacterial or fungal overgrowth of nonsusceptible organisms may occur with prolonged or repeated therapy |
Inhaled recombinant human deoxyribonuclease is a mucolytic agent successfully used in patients with cystic fibrosis.
| Drug Name | Dornase alfa (Pulmozyme) |
|---|---|
| Description | Cleaves and depolymerizes extracellular DNA and separates DNA from proteins. This allows endogenous proteolytic enzymes to break down the proteins; thus, decreasing viscoelasticity and surface tension of purulent sputum. |
| Adult Dose | 2.5 mg/d via nebulizer; some patients (especially patients >21 y or with FVC >85%) may benefit from administering bid |
| Pediatric Dose | Administer as in adults |
| Contraindications | Documented hypersensitivity |
| Interactions | None reported |
| Pregnancy | B - Usually safe but benefits must outweigh the risks. |
| Precautions | May cause hoarseness, pharyngitis, rash, or chest pain |
| Media file 1: Atelectasis. Left lower lobe collapse. The opacity is in the posterior inferior location. | |
![]() | View Full Size Image | Media type: X-RAY |
| Media file 2: Atelectasis. Loss of volume on the left side; an elevated and silhouetted left diaphragm; and an opacity behind the heart, called a sail sign, are present. | |
![]() | View Full Size Image | Media type: X-RAY |
| Media file 3: Atelectasis. Left upper lobe collapse showing opacity contiguous to the aortic knob, a smaller left hemithorax, and a mediastinal shift. | |
![]() | View Full Size Image | Media type: X-RAY |
| Media file 4: Atelectasis. CT scan of a left upper lobe collapse with a small pleural effusion. | |
![]() | View Full Size Image | Media type: CT |
| Media file 5: Complete atelectasis of the left lung. Mediastinal displacement, opacification, and loss of volume are present in the left hemithorax. | |
![]() | View Full Size Image | Media type: X-RAY |
| Media file 6: Atelectasis. Right lower lobe collapse. | |
![]() | View Full Size Image | Media type: X-RAY |
| Media file 7: Atelectasis. Both right lower lobe and right middle lobe collapse. The left lung is hyperexpanded. | |
![]() | View Full Size Image | Media type: X-RAY |
| Media file 8: Complete right lung atelectasis. | |
![]() | View Full Size Image | Media type: X-RAY |
| Media file 9: Atelectasis. A lateral chest x-ray film confirms the diagnosis of right middle lobe collapse. The minor fissure moves down, and the major fissure moves up, leading to a wedge-shaped opacity. | |
![]() | View Full Size Image | Media type: X-RAY |
| Media file 10: Atelectasis. The left upper lobe collapses anteriorly on a lateral chest x-ray film. | |
![]() | View Full Size Image | Media type: X-RAY |
| Media file 11: Atelectasis. Left upper lobe collapse. The top of the aortic knob sign is demonstrated. | |
![]() | View Full Size Image | Media type: X-RAY |
| Media file 12: Atelectasis. Left lower lobe collapse. | |
![]() | View Full Size Image | Media type: X-RAY |
| Media file 13: Atelectasis. Right middle lobe collapse shows obliteration of the right heart border. | |
![]() | View Full Size Image | Media type: X-RAY |
| Media file 14: Atelectasis. The azygous lobe of the right lung may be mistaken for a collapsed right upper lobe. | |
![]() | View Full Size Image | Media type: X-RAY |
| Media file 15: Atelectasis. Left lower lobe collapse. The sail sign is obvious. | |
![]() | View Full Size Image | Media type: X-RAY |
| Media file 16: Atelectasis. Left upper lobe collapse. The Luft Sichel sign is demonstrated clearly in this radiograph. | |
![]() | View Full Size Image | Media type: X-RAY |
| Media file 17: Atelectasis. Chest CT scan showing left upper lobe collapse. | |
![]() | View Full Size Image | Media type: CT |
| Media file 18: Atelectasis. The right lower lobe collapses inferiorly and posteriorly. | |
![]() | View Full Size Image | Media type: X-RAY |
| Media file 19: Atelectasis. Right lower lobe collapse without middle lobe collapse, the right major fissure is shifted downward and is now visible. | |
![]() | View Full Size Image | Media type: X-RAY |
| Media file 20: Atelectasis. Right upper lobe collapse demonstrating Golden sign of S. | |
![]() | View Full Size Image | Media type: X-RAY |
| Media file 21: Atelectasis. Right middle lobe collapse showing obliteration of the right heart border. | |
![]() | View Full Size Image | Media type: X-RAY |
| Media file 22: Atelectasis. Right middle lobe collapse on a lateral chest x-ray film. | |
![]() | View Full Size Image | Media type: X-RAY |
| Media file 23: Atelectasis. Right upper lobe collapse and consolidation. | |
![]() | View Full Size Image | Media type: X-RAY |
| Media file 24: Atelectasis. Right upper lobe collapse. | |
![]() | View Full Size Image | Media type: CT |
| Media file 25: Atelectasis. Right upper lobe collapse. | |
![]() | View Full Size Image | Media type: X-RAY |
| Media file 26: Atelectasis. Left lower lobe collapse on posteroanterior view. | |
![]() | View Full Size Image | Media type: X-RAY |
| Media file 27: The left lower lobe collapses toward the posterior and inferior aspects of the thoracic cavity; the atelectatic left lower lobe is present as a sail behind the cardiac shadow. | |
![]() | View Full Size Image | Media type: |
Article Last Updated: Jun 14, 2006